Symbravo (meloxicam/rizatriptan) — CareFirst (Caremark)
Acute treatment of migraine with or without aura in adults and pediatric patients age ≥ 12 years (Treximet)
Preferred products
- generic sumatriptan
- generic naproxen
- generic meloxicam
- generic rizatriptan
Initial criteria
- Diagnosis of migraine headache
- Patient has tried and experienced an inadequate treatment response or intolerance to THREE triptan 5-HT1 agonists
- Patient has tried the two individual components of the requested drug taken together [i.e., (meloxicam plus rizatriptan) or (naproxen plus sumatriptan)]
Approval duration
12 months